Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss emerging efficacy and safety data on new agents for hepatitis B
- Describe long-term treatment data on the management of hepatitis B
- Summarize strategies for managing patients with resistance or suboptimal responses
- Discuss factors associated with treatment outcomes in hepatitis B
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.